Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Trichloroethylene is a volatile halogenated hydrocarbon historically used as an anesthetic and currently classified as an antiseptic and solvent in plant allergenic extract processing. It requires strict clinical oversight due to its significant toxicological profile.
Name
Trichloroethylene
Raw Name
TRICHLOROETHYLENE
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
4
Variant Count
4
Last Verified
February 17, 2026
About Trichloroethylene
Trichloroethylene is a volatile halogenated hydrocarbon historically used as an anesthetic and currently classified as an antiseptic and solvent in plant allergenic extract processing. It requires strict clinical oversight due to its significant toxicological profile.
Detailed information about Trichloroethylene
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Trichloroethylene.
Trichloroethylene (TCE) is a clear, colorless, volatile liquid with a sweet, chloroform-like odor. Chemically, it is a chlorinated hydrocarbon with the formula C2HCl3. In the realm of clinical pharmacology and the FDA's Established Pharmacologic Class (EPC), Trichloroethylene is categorized as a Non-Standardized Plant Allergenic Extract [EPC] and an Antiseptic [EPC]. Historically, it occupied a prominent place in medicine as a general anesthetic and analgesic, particularly in obstetrics and minor surgical procedures, marketed under trade names such as Trilene and Trimar. However, its therapeutic window is narrow, and its use has largely shifted from direct clinical administration to industrial and laboratory applications, including its role as a solvent in the preparation of allergenic extracts.
Trichloroethylene belongs to the class of halogenated hydrocarbons. When used as a 'Non-Standardized Plant Allergenic Extract,' it typically functions as a processing agent or solvent used to extract specific proteins or compounds from botanical sources. As an antiseptic, its volatile nature and lipid-solubility allow it to disrupt microbial membranes, though it is rarely the first choice in modern clinical settings due to the availability of safer alternatives. The FDA history of Trichloroethylene is complex; while it was once widely used in the mid-20th century, growing evidence of its neurotoxicity, hepatotoxicity, and carcinogenicity led to its discontinuation as a general anesthetic in the United States by the late 1970s.
At the molecular level, Trichloroethylene acts as a potent central nervous system (CNS) depressant. While its exact mechanism of action as an anesthetic was never fully elucidated using modern neuroimaging, it is known to interact with lipid bilayers of neuronal membranes. Like other halogenated hydrocarbons, it is believed to modulate the activity of gamma-aminobutyric acid (GABA-A) receptors and glycine receptors, enhancing inhibitory neurotransmission. Simultaneously, it inhibits excitatory pathways, such as those mediated by N-methyl-D-aspartate (NMDA) receptors. This dual action results in the progressive depression of the CNS, starting with analgesia and moving toward complete anesthesia.
In its role as an antiseptic, Trichloroethylene works through the denaturation of proteins and the dissolution of bacterial lipid membranes. Its high volatility ensures rapid evaporation, which was historically useful for preparing the skin for injections or surgical incisions. However, its efficacy is lower than that of modern iodophors or chlorhexidine solutions.
The pharmacokinetics of Trichloroethylene are characterized by rapid absorption and complex metabolism, which is a primary driver of its toxicity.
While no longer used as a primary anesthetic, Trichloroethylene remains relevant in specific clinical and industrial contexts:
Trichloroethylene is not typically available as a standard prescription medication for patient self-administration. It is found in:
> Important: Only your healthcare provider can determine if any product containing Trichloroethylene derivatives or extracts processed with it is appropriate for your specific clinical needs. Due to its toxicity, direct exposure is strictly regulated.
There is no established standard oral or injectable dosage for Trichloroethylene in modern clinical practice for patients. Its use is primarily restricted to industrial, laboratory, or specialized clinical processing environments.
Trichloroethylene is NOT approved for pediatric use. Historically, its use in children was associated with a higher risk of cardiac arrhythmias and respiratory depression. In modern medicine, there is no indication for the administration of TCE to children. Exposure in pediatric populations is usually accidental or environmental and is considered a medical emergency.
Because Trichloroethylene is not a standard therapeutic drug, there are no established dosage adjustment protocols. However, its toxicological impact is significantly altered by the following factors:
Patients with pre-existing renal disease are at a significantly higher risk of nephrotoxicity from TCE exposure. The glutathione conjugation pathway in the kidneys produces toxic thioamides that can cause acute tubular necrosis. Any exposure in patients with impaired kidney function must be avoided.
As the liver is the primary site of CYP2E1-mediated metabolism, hepatic impairment can lead to decreased clearance of TCE and increased risk of hepatotoxicity. Patients with cirrhosis or hepatitis are particularly vulnerable to the toxic effects of TCE metabolites.
Elderly patients are at increased risk for CNS depression and cardiac sensitization. Age-related declines in hepatic and renal function mean that even trace exposures (such as those found in environmental contamination) can have more profound effects on this population.
Trichloroethylene is not intended for self-administration. In professional settings where it is used as a solvent or antiseptic:
This section is not applicable as Trichloroethylene is not administered on a chronic dosing schedule. If a clinical procedure involving a TCE-processed extract is missed, contact your healthcare provider for rescheduling instructions.
Trichloroethylene overdose is a life-threatening emergency. It most commonly occurs through accidental inhalation in industrial settings or ingestion.
> Important: Follow your healthcare provider's instructions regarding any products processed with Trichloroethylene. Do not attempt to use industrial-grade Trichloroethylene for any medical purpose.
Direct exposure to Trichloroethylene, particularly through inhalation of vapors, frequently causes immediate central nervous system effects. These include:
These effects are typically transient if the individual is removed from the source of exposure but can persist for several hours due to the accumulation of metabolites like trichloroethanol.
> Warning: Stop using any product containing Trichloroethylene and seek emergency medical care immediately if you experience any of the following:
Prolonged or chronic exposure to Trichloroethylene is associated with severe systemic health issues:
While Trichloroethylene does not have a traditional FDA Black Box warning in the context of a modern prescription drug (as it is not an approved systemic medication), the following safety mandates apply to its use in clinical and industrial settings:
Report any unusual symptoms or suspected exposures to your healthcare provider or local poison control center immediately.
Trichloroethylene is a hazardous substance with significant toxicological risks. It is not intended for general consumer use. All medical applications involving TCE (such as in the processing of allergenic extracts) must be conducted under strict regulatory compliance and quality control. Patients should be aware that environmental exposure to TCE (e.g., via contaminated groundwater or soil vapor intrusion) is a major public health concern.
No FDA black box warnings for Trichloroethylene exist in the traditional sense because it is not an FDA-approved prescription drug for self-administration. However, the EPA and OSHA provide 'Danger' labels for industrial use, highlighting its status as a human carcinogen and a potent neurotoxin.
For individuals with potential occupational or environmental exposure to Trichloroethylene, the following monitoring is recommended:
Exposure to Trichloroethylene vapors causes significant impairment of motor skills, coordination, and judgment. Individuals exposed to TCE must not drive or operate heavy machinery until all symptoms of CNS depression have completely resolved and they have been cleared by a medical professional.
Alcohol must be strictly avoided during and after exposure to Trichloroethylene. Alcohol competes for the same metabolic enzymes (CYP2E1) as TCE. This interaction can lead to a condition known as 'Degreaser's Flush,' characterized by extreme redness of the face, neck, and back, along with tachycardia and nausea. Alcohol also potentiates the CNS depressant effects of TCE, increasing the risk of respiratory failure.
As TCE is not a maintenance medication, there are no tapering requirements. However, individuals being removed from a chronic exposure environment may experience 'withdrawal' symptoms such as irritability, sleep disturbances, and headaches as the body clears the accumulated metabolites.
> Important: Discuss all your medical conditions and potential environmental exposures with your healthcare provider before starting any treatment involving extracts processed with Trichloroethylene.
For each major interaction, the mechanism involves either pharmacodynamic synergy (additive CNS depression) or pharmacokinetic interference (competition for CYP2E1). The clinical consequence is typically increased toxicity rather than reduced efficacy. Management involves immediate cessation of exposure and supportive care.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially if you work in an environment where Trichloroethylene is used.
Trichloroethylene must NEVER be used or encountered in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Individuals who have had adverse reactions to other halogenated solvents or anesthetics, such as Chloroform, Halothane, or Perchloroethylene (dry cleaning fluid), may exhibit cross-sensitivity to Trichloroethylene. The similar chemical structures often result in similar metabolic pathways and toxicological profiles.
> Important: Your healthcare provider will evaluate your complete medical history, including occupational history, before prescribing any treatment that may involve Trichloroethylene-processed materials.
Trichloroethylene is classified as a significant reproductive hazard. According to data from the EPA and various epidemiological studies, maternal exposure to TCE via contaminated drinking water or inhalation is associated with an increased risk of congenital heart defects (specifically left-sided obstructive lesions) in the fetus. TCE and its metabolites readily cross the placenta. It is also linked to an increased risk of miscarriage and low birth weight. Exposure during pregnancy should be strictly avoided.
Trichloroethylene is lipophilic and is known to be excreted in human breast milk. While data on the exact concentration in milk versus maternal plasma is limited, the potential for neonatal CNS depression and long-term developmental effects is high. Breastfeeding is not recommended if the mother has been recently exposed to significant levels of TCE.
Trichloroethylene is not approved for use in children. Pediatric populations are particularly vulnerable to the neurotoxic effects of TCE. Chronic environmental exposure in children has been tentatively linked to neurodevelopmental delays and an increased risk of childhood leukemia, although more definitive research is needed. Any pediatric exposure must be treated as a toxicological emergency.
Elderly patients are at a higher risk for adverse effects from TCE due to the natural decline in hepatic and renal clearance. There is also an increased risk of falls and hip fractures due to the CNS depressant effects (dizziness and ataxia). Furthermore, the sensitization of the heart to catecholamines is particularly dangerous in elderly patients with underlying coronary artery disease or heart failure.
In patients with renal impairment, the clearance of trichloroacetic acid (TCA) is significantly delayed. This leads to a prolonged presence of metabolites in the system, increasing the risk of further kidney damage. Dosage of any TCE-processed extract must be handled with extreme caution, though generally, the residual amounts are negligible in standardized products.
As the primary site of metabolism, the liver is both the processor and the target of TCE. Hepatic impairment (Child-Pugh Class B or C) significantly increases the half-life of TCE and the risk of centrilobular necrosis. Patients with hepatic impairment should avoid all potential sources of TCE exposure.
> Important: Special populations require individualized medical assessment and strict avoidance of environmental toxins like Trichloroethylene.
Trichloroethylene acts primarily as a non-specific central nervous system depressant. Its molecular mechanism involves the modulation of ligand-gated ion channels. It enhances the activity of GABA-A and glycine receptors, which are the brain's primary inhibitory signaling pathways. By increasing chloride ion conductance, it hyperpolarizes neurons, making them less likely to fire. Additionally, TCE inhibits NMDA receptors and certain voltage-gated calcium channels, reducing excitatory neurotransmission. In the heart, TCE interacts with myocardial cell membranes, altering their stability and making them hypersensitive to the arrhythmogenic effects of epinephrine.
The dose-response relationship of TCE is steep. Low-level exposure leads to analgesia and mild sedation. As the concentration increases, it induces surgical anesthesia, followed by respiratory center depression in the medulla. The duration of effect for a single acute exposure is relatively short (30-60 minutes for the parent compound), but the metabolites can exert sedative effects for several days. Tolerance to the CNS effects can develop with chronic occupational exposure, often leading to 'solvent abuse' patterns.
| Parameter | Value |
|---|---|
| Bioavailability | 40-70% (Inhalation); ~90% (Oral) |
| Protein Binding | ~80% (Metabolites like TCA) |
| Half-life | 2-4 hours (Parent); 70-100 hours (TCA metabolite) |
| Tmax | 0.5 - 1 hour (Inhalation) |
| Metabolism | Hepatic (CYP2E1) to Chloral Hydrate, TCA |
| Excretion | Pulmonary (Unchanged); Renal (Metabolites) |
Trichloroethylene is classified as a Halogenated Hydrocarbon. Within the therapeutic context, it is an Inhalation Anesthetic (Historical) and an Antiseptic/Solvent (Current). It is related to other chlorinated solvents like tetrachloroethylene (PCE) and carbon tetrachloride.
Common questions about Trichloroethylene
Historically, Trichloroethylene was used as a general anesthetic for surgery and childbirth because of its potent pain-relieving properties. In modern medicine, it is no longer used directly on patients but serves as a critical solvent in the processing of non-standardized plant allergenic extracts. These extracts are used by specialists to diagnose and treat allergies. It also has historical roots as an antiseptic for skin disinfection. Outside of medicine, it is widely used as an industrial degreaser for metal parts. Because of its toxicity, its use is strictly regulated by health and environmental agencies.
The most common side effects of Trichloroethylene exposure involve the central nervous system, such as dizziness, headache, nausea, and a feeling of intoxication. Many people describe a 'sweet' taste in their mouth followed by a sense of lightheadedness or confusion. If the liquid touches the skin, it can cause redness, burning, and dryness, often called 'degreaser's dermatitis.' These symptoms usually appear quickly after inhalation or skin contact. If you experience these symptoms in a workplace or clinical setting, you should move to fresh air and seek medical advice immediately.
No, you must never drink alcohol if you have been exposed to Trichloroethylene. Alcohol and Trichloroethylene are processed by the same enzymes in the liver, leading to a dangerous interaction. This can cause 'Degreaser's Flush,' a condition where the skin on the face and neck turns bright red and itchy. Alcohol also significantly increases the sedative effects of Trichloroethylene, which can lead to dangerous levels of drowsiness or even respiratory failure. It is best to avoid alcohol for at least several days following any significant exposure to this chemical.
Trichloroethylene is not considered safe during pregnancy and is linked to serious developmental risks. Research has shown that exposure to TCE in contaminated drinking water or air can increase the risk of heart defects in the developing fetus. It is also associated with a higher rate of miscarriage and other pregnancy complications. Because TCE can cross the placenta easily, it directly affects fetal development. If you are pregnant or planning to become pregnant, you should avoid any environment where Trichloroethylene is used or where groundwater contamination is suspected.
When used as an anesthetic or inhaled accidentally, Trichloroethylene works very rapidly, often within seconds to minutes. Its high lipid solubility allows it to cross the blood-brain barrier almost immediately, leading to quick sedation or analgesia. However, while the initial 'high' or anesthetic effect may wear off quickly once exposure stops, the body takes much longer to fully clear the chemical. Some of its metabolites can stay in the bloodstream for nearly a week. This long clearance time is why repeated exposures can lead to a buildup of toxins in the liver and kidneys.
Since Trichloroethylene is not a medication that patients take on a regular schedule, 'stopping' it usually refers to ending an occupational or environmental exposure. There is no medical requirement to taper off the substance, but people who have been exposed long-term may experience a period of adjustment. Symptoms like headaches, irritability, and fatigue may occur as the body processes the remaining metabolites. If you have been chronically exposed, it is important to have a full medical evaluation to check for long-term damage to the liver, kidneys, or nervous system. Always consult a doctor if you are concerned about past exposure.
This situation is rare because Trichloroethylene is not a standard prescription drug. If you were scheduled for an allergy treatment that uses extracts processed with TCE and you miss your appointment, simply contact your allergist to reschedule. There is no 'dose' to make up at home. If you are referring to a clinical procedure where TCE was to be used as an antiseptic, your healthcare provider will simply use an alternative agent or reschedule the procedure. Never attempt to source or use Trichloroethylene on your own.
There is no clinical evidence that Trichloroethylene causes weight gain in humans. In fact, chronic exposure to high levels of TCE is more likely to cause weight loss due to chronic nausea, loss of appetite (anorexia), and the systemic stress of organ toxicity. Some animal studies have looked at metabolic changes following TCE exposure, but these do not translate to weight gain in a clinical setting. If you are experiencing unexplained weight changes and suspect chemical exposure, you should discuss this with your doctor to rule out liver or kidney issues.
Trichloroethylene has dangerous interactions with many medications and should not be combined with other drugs. It is particularly dangerous when combined with adrenaline (epinephrine), as this can cause the heart to stop beating correctly. It also interacts poorly with other sedatives, such as sleep aids, anxiety medications, and strong painkillers, which can dangerously slow your breathing. Because TCE affects the liver, it can also change how your body processes many other common prescriptions. Always provide your doctor with a full list of your medications if you have been exposed to TCE.
Trichloroethylene is a basic chemical compound and is not sold as a generic prescription drug for patient use. It is available as a technical-grade or ACS-grade chemical for industrial and laboratory purposes. While it was once sold under various brand names for anesthesia, those medical products have been discontinued in the United States and many other countries. Any product you encounter today containing Trichloroethylene is likely an industrial solvent or a specialized laboratory reagent, not a medication intended for home use.